New Models of Hemostasis

Topics in Companion Animal Medicine

Volumn 27, Issue 2, 2012, Pages 40-45

  McMichael, Maureen ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Cascade model; Cell based model; Coagulation; Thrombosis; Waterfall model

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; COAGULATING AGENT;

ANIMAL; BIOLOGICAL MODEL; BLOOD; BLOOD CLOTTING; CAT; DOG; DRUG EFFECT; HOMEOSTASIS; METABOLISM; PHYSIOLOGY; REVIEW; THROMBOCYTE;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; CATS; COAGULANTS; DOGS; HOMEOSTASIS; MODELS, BIOLOGICAL;

EID: 84866999202     PISSN: 19389736     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tcam.2012.07.005     Document Type: Review

References (69)

1. Seegers W.H. Basic enzymology of blood coagulation. Thromb Diath Haemorrh 1965, 14:213-228.
2. Seegers W.H., Alkjaersig N., Johnson S.A. On the nature of the blood coagulation mechanisms in certain clinical states. Am J Clin Pathol 1955, 25:983-987.
3. Rosenthal R.L., Dreskin O.H., Rosenthal N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med 1953, 82:171-174.
4. Hougie C., Barrow E.M., Graham J.B. Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency. J Clin Invest 1957, 36:485-496.
5. Davie E.W., Ratnoff O.D. Waterfall sequence for intrinsic blood clotting. Science 1964, 145:1310-1312.
6. MacFarlane R.G. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964, 202:498-499.
7. Mann K.G., Krishnaswamy S., Lawson J.H. Surface-dependent hemostasis. Semin Hematol 1992, 29:213-226.
8. Davie E.W. A brief historical review of the waterfall/cascade of blood coagulation. J Biol Chem 2003, 278:50819-50832.
9. Hathaway W.E., Belhasen L.P., Hathaway H.S. Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties. Blood 1965, 26:521-532.
10. Wuepper K.D. Prekallikrein deficiency in man. J Exp Med 1973, 138:1345-1355.
11. Schiffman S., Lee P., Feinstein D.I., Pecci R. Relationship of contact activation cofactor (CAC) procoagulant activity to kininogen. Blood 1977, 49:935-945.
12. Colman R.W., Bagdasarian A., Talamo R.C., et al. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest 1975, 56:1650-1662.
13. Saito H., Ratnoff O.D., Waldmann R., Abraham J.P. Fitzgerald trait: deficiency of a hitherto unrecognized agent, Fitzgerald factor, participating in surface-mediated reactions of clotting, fibrinolysis, generation of kinins, and the property of diluted plasma enhancing vascular permeability (PF/Dil). J Clin Invest 1975, 55:1082-1089.
14. Smith S.A. Overview of hemostasis. Schlam's Veterinary Hematology 2011, 635-653. Lippincott Williams and Wilkins, Philadelphia, PA. D. Weiss, J. Wardrop (Eds.).
15. Smith S.A., McMichael M., Galligan A., Gilor S., Hoh C.M. Clot formation in canine whole blood as measured by rotational thromboelastometry is influenced by sample handling and coagulation activator. Blood Coagul Fibrinolysis 2010, 21:692-702.
16. Schmaier A.H. The elusive physiologic role of Factor XII. J Clin Invest 2008, 118:3006-3009.
17. Emsley J., McEwan P.A., Gailani D. Structure and function of factor XI. Blood 2010, 115:2569-2577.
18. Müller F., Renné T. Novel roles for factor XII-driven plasma contact activation system. Curr Opin Hematol 2008, 15:516-521.
19. Renné T., Pozgajová M., Grüner S., et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005, 202:271-281.
20. Gailani D., Renné T. Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol 2007, 27:2507-2513.
21. Gailani D., Renné T. The intrinsic pathway of coagulation: a target for treating thromboembolic disease?. J Thromb Haemost 2007, 5:1106-1112.
22. van der Meijden P.E., Van S.M., Van Schilfgaarde M., Renné T., Ten Cate H., Spronk H.M. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. J Thromb Haemost 2012, 10:1355-1362.
23. Salomon O., Steinberg D.M., Koren-Morag N., Tanne D., Seligsohn U. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood 2008, 111:4113-4117.
24. Morrissey J.H. Polyphosphate: a link between platelets, coagulation and inflammation. Int J Hematol 2012, 95:346-352.
25. Morrissey J.H., Choi S.H., Smith S.A. Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. Blood 2012, 119:5972-5979.
26. Smith S.A., Mutch N.J., Baskar D., Rohloff P., Docampo R., Morrissey J.H. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci U S A 2006, 103:903-908.
27. Smith S.A., Choi S.H., Davis-Harrison R., et al. Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood 2010, 116:4353-4359.
28. Choi S.H., Collins J.N., Smith S.A., Davis-Harrison R.L., Rienstra C.M., Morrissey J.H. Phosphoramidate end labeling of inorganic polyphosphates: facile manipulation of polyphosphate for investigating and modulating its biological activities. Biochemistry 2010, 49:9935-9941.
29. Colman R.W., Schmaier A.H. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 1997, 90:3819-3843.
30. Walsh P., Gailani D. Factor XI. Hemostasis and Thrombosis: Basic Principles and Clinical Practice 2006, 221-233. Lippincott Williams and Wilkins, Philadelphia, PA. R.W. Coleman, V.J. Marder, A.W. Clowes, J.N. George, S.Z. Goldhaber (Eds.).
31. Naito K., Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 1991, 266:7353-7358.
32. Gailani D., Broze G.J. Factor XI activation in a revised model of blood coagulation. Science 1991, 253:909-912.
33. Gailani D., Broze G.J. Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation. iBlood 1993, 82:813-819.
34. Gailani D., Broze G.J. Effects of glycosaminoglycans on factor XI activation by thrombin. Blood Coagul Fibrinolysis 1993, 4:15-20.
35. Choi S.H., Smith S.A., Morrissey J.H. Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood 2011, 118:6963-6970.
36. Brown M.R., Kornberg A. The long and short of it-polyphosphate, PPK and bacterial survival. Trends Biochem Sci 2008, 33:284-290.
37. Jacobsen S., Kriz M. Some data on two purified kininogens from human plasma. Br J Pharmacol Chemother 1967, 29:25-36.
38. Ghebrehiwet B., Randazzo B.P., Dunn J.T., Silverberg M., Kaplan A.P. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. J Clin Invest 1983, 71:1450-1456.
39. Colman R.W., Jameson B.A., Lin Y., Johnson D., Mousa S.A. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Blood 2000, 95:543-550.
40. Loza J.P., Gurewich V., Johnstone M., Pannell R. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis. Thromb Haemost 1994, 71:347-352.
41. Ben Nasr A., Wistedt A., Ringdahl U., Sjöbring U. Streptokinase activates plasminogen bound to human group C and G streptococci through M-like proteins. Eur J Biochem 1994, 222:267-276.
42. Kalter E.S., van Dijk W.C., Timmerman A., Verhoef J., Bouma B.N. Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus. J Infect Dis 1983, 148:682-691.
43. Osterud B., Rapaport S.I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A 1977, 74:5260-5264.
44. Marlar R.A., Kleiss A.J., Griffin J.H. An alternative extrinsic pathway of human blood coagulation. Blood 1982, 60:1353-1358.
45. Furie B., Furie B.C. Thrombus formation in vivo. J Clin Invest 2005, 115:3355-3362.
46. Ananyeva N.M., Kouiavskaia D.V., Shima M., Saenko E.L. Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque. Blood 2002, 99:4475-4485.
47. Tanaka K.A., Key N.S., Levy J.H. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg 2009, 108:1433-1446.
48. Morrissey J.H., Tajkhorshid E., Sligar S.G., Rienstra C.M. Tissue factor/factor VIIa complex: role of the membrane surface. Thromb Res 2012, 129(suppl 2):S8-S10.
49. Morrissey J.H. Plasma factor VIIa: measurement and potential clinical significance. Haemostasis 1996, 26(suppl 1):66-71.
50. Wildgoose P., Nemerson Y., Hansen L.L., Nielsen F.E., Glazer S., Hedner U. Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood 1992, 80:25-28.
51. Smith S.A. The cell-based model of coagulation. J Vet Emerg Crit Care (San Antonio) 2009, 19:3-10.
52. Hoffman M. A cell-based model of coagulation and the role of factor VIIa. Blood Rev 2003, 17(suppl 1):S1-S5.
53. Baugh R.J., Broze G.J., Krishnaswamy S. Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J Biol Chem 1998, 273:4378-4386.
54. Lu G., Broze G.J., Krishnaswamy S. Formation of factors IXa and Xa by the extrinsic pathway: differential regulation by tissue factor pathway inhibitor and antithrombin III. J Biol Chem 2004, 279:17241-17249.
55. Berntorp E., Shapiro A.D. Modern haemophilia care. Lancet 2012, 379:1447-1456.
56. Booth N., Bachman F. Plasminogen-plasmin system. Hemostasis and Thrombosis: Basic Principles and Clinical Practice 2006, 335-365. Lippincott Williams Wilkins, Philadelphia, PA. R.W. Coleman, V.J. Marder, A.W. Clowes, J.N. George, S.Z. Goldhaber (Eds.).
57. Rosenberg R.D., Aird W.C. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999, 340:1555-1564.
58. del Zoppo G.J., Hawkins B.T. Throwing out the thromboemboli. N Engl J Med 2010, 363:1282-1284.
59. Sappino A.P., Madani R., Huarte J., et al. Extracellular proteolysis in the adult murine brain. J Clin Invest 1993, 92:679-685.
60. Lam C.K., Yoo T., Hiner B., Liu Z., Grutzendler J. Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization. Nature 2010, 465:478-482.
61. Herring J.M. Procoagulant microparticles in stored canine erythrocyte concentrates [abstract]. J Vet Emerg Clin Care 2011, 21:S5.
62. Schmid-Schönbein G.W., Usami S., Skalak R., Chien S. The interaction of leukocytes and erythrocytes in capillary and postcapillary vessels. Microvasc Res 1980, 19:45-70.
63. Tangelder G.J., Arfors K.E. Inhibition of leukocyte rolling in venules by protamine and sulfated polysaccharides. Blood 1991, 77:1565-1571.
64. Furie B., Furie B.C. Mechanisms of thrombus formation. N Engl J Med 2008, 359:938-949.
65. Dubois C., Panicot-Dubois L., Merrill-Skoloff G., Furie B., Furie B.C. Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. Blood 2006, 107:3902-3906.
66. Mangin P., Yap C.L., Nonne C., et al. Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRgamma deficiency. Blood 2006, 107:4346-4353.
67. Ni H., Denis C.V., Subbarao S., et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000, 106:385-392.
68. Butenas S., Bouchard B.A., Brummel-Ziedins K.E., Parhami-Seren B., Mann K.G. Tissue factor activity in whole blood. Blood 2005, 105:2764-2770.
69. Cho J., Furie B.C., Coughlin S.R., Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest 2008, 118:1123-1131.